Sampling in the case‐time‐control design among drug users when outcome prevents further treatment-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Sampling in the case‐time‐control design among drug users when outcome prevents further treatment

Published:2022-02-07 Issue:4 Volume:31 Page:404-410
ISSN:1053-8569
Container-title:Pharmacoepidemiology and Drug Safety
language:en
Short-container-title:Pharmacoepidemiology and Drug

Author:

Madsen Jeppe Ekstrand Halkjær¹²^ORCID,Hallas Jesper³^ORCID,Delvin Thomas¹,Scheike Thomas²,Pipper Christian¹

Affiliation:

1. Biostatistics and Pharmacoepidemiology, Medical Sciences Leo Pharma A/S Ballerup Denmark

2. Section of Biostatistics, Department of Public Health University of Copenhagen Copenhagen K Denmark

3. Clinical Pharmacology, Pharmacy and Environmental Medicine, Department of Public Health University of Southern Denmark Odense Denmark

Funder

Innovationsfonden

Publisher

Wiley

Subject

Pharmacology (medical),Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pds.5410

Reference13 articles.

1. Use of self-controlled designs in pharmacoepidemiology

2. Control yourself: ISPE‐endorsed guidance in the application of self‐controlled study designs in pharmacoepidemiology

3. The Case-Crossover Design: A Method for Studying Transient Effects on the Risk of Acute Events

4. Bidirectional Case-Crossover Designs for Exposures with Time Trends

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP